Abstract
Activation-induced cell death (AICD) is an active process. T and B lymphocytes undergo AICD as an auto-regulatory mechanism for the body to remove unwanted activated cells after making appropriate use of them. Recent studies have shown that brain microglia and astrocytes also undergo apoptosis upon inflammatory activation. Caspase-11 has been demonstrated to play a central role in the apoptosis of both microglia and astrocytes following inflammatory activation; inflammatory stimuli induce neuroglial apoptosis through caspases-11, -1, and -3. Thus, inflammatory signals that activate neuroglia may also initiate internal death program, in which caspases play a crucial role. Caspases may be a target for the modulation of neuroglial AICD that has implications in neurodegenerative diseases.
Keywords: apoptosis, caspase, microglia, astrocyte, nitric oxide, inflammation, signal transduction, neurodegenerative diseases
Current Enzyme Inhibition
Title: Role of Caspases in Activation-Induced Cell Death of Neuroglia
Volume: 1 Issue: 1
Author(s): Kyoungho Suk
Affiliation:
Keywords: apoptosis, caspase, microglia, astrocyte, nitric oxide, inflammation, signal transduction, neurodegenerative diseases
Abstract: Activation-induced cell death (AICD) is an active process. T and B lymphocytes undergo AICD as an auto-regulatory mechanism for the body to remove unwanted activated cells after making appropriate use of them. Recent studies have shown that brain microglia and astrocytes also undergo apoptosis upon inflammatory activation. Caspase-11 has been demonstrated to play a central role in the apoptosis of both microglia and astrocytes following inflammatory activation; inflammatory stimuli induce neuroglial apoptosis through caspases-11, -1, and -3. Thus, inflammatory signals that activate neuroglia may also initiate internal death program, in which caspases play a crucial role. Caspases may be a target for the modulation of neuroglial AICD that has implications in neurodegenerative diseases.
Export Options
About this article
Cite this article as:
Suk Kyoungho, Role of Caspases in Activation-Induced Cell Death of Neuroglia, Current Enzyme Inhibition 2005; 1 (1) . https://dx.doi.org/10.2174/1573408052952757
DOI https://dx.doi.org/10.2174/1573408052952757 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Gene Therapy Targeting Nuclear Factor-κB: Towards Clinical Application in Inflammatory Diseases and Cancer
Current Gene Therapy Regulation of Self-Reactive T Cells by Human Immunoglobulins- Implications for Multiple Sclerosis Therapy
Current Pharmaceutical Design “Something is Wrong in the Ras Kingdom” - Evidence for the Involvement of p21Ras/MAP Kinase in Autoimmune Diseases
Current Rheumatology Reviews Gene Therapy for Immunologic Tolerance: Using Bone Marrow-Derived Cells to Treat Autoimmunity and Hemophilia
Current Stem Cell Research & Therapy Complex and Differential Glial Responses in Alzheimer´s Disease and Ageing
Current Alzheimer Research The Opposite Effect of L-kynurenine and Ahr Inhibitor Ch223191 on Apoptotic Protein Expression in Pancreatic Carcinoma Cells (Panc-1)
Anti-Cancer Agents in Medicinal Chemistry Sympathetic Nervous System Dysfunction in Multiple Sclerosis, Linking Neurodegeneration to a Reduced Response to Therapy
Current Pharmaceutical Design Mesenchymal Stem Cells Targeting of Systemic Disorders in Age-related Macular Degeneration
Current Tissue Engineering (Discontinued) Nasal Drug Delivery System-Factors Affecting and Applications
Current Drug Therapy Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing- Remitting Multiple Sclerosis
Current Pharmaceutical Design Traumatic Brain Injury and Blood-Brain Barrier Cross-Talk
CNS & Neurological Disorders - Drug Targets Adverse Reactions Induced by Minocycline: A Review of Literature
Current Drug Safety Updating the Chemistry and Biology of Cannabinoid CB2 Receptor – Specific Inverse Agonists
Current Topics in Medicinal Chemistry Respiratory Tolerance in the Protection Against Asthma
Current Drug Targets - Inflammation & Allergy Therapeutic Indications and Action Mechanisms of Bilirubin: Suggestions from Natural Calculus Bovis
Current Signal Transduction Therapy Importance of ABC Transporters in Drug Development
Current Pharmaceutical Design Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders
Current Topics in Medicinal Chemistry New Kid on the Block: Does Histamine Get Along with Inflammation in Amyotrophic Lateral Sclerosis?
CNS & Neurological Disorders - Drug Targets Inhibition of Transcription Factors by Plant-Derived Compounds and their Implications in Inflammation and Cancer
Current Pharmaceutical Design Curcumin: the Yellow Molecule with Pleiotropic Biological Effects
Letters in Drug Design & Discovery